• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在切除的肝癌中产生抗肿瘤活性免疫球蛋白的肿瘤浸润性B细胞可延长患者生存期。

Tumor-infiltrating B cells producing antitumor active immunoglobulins in resected HCC prolong patient survival.

作者信息

Brunner Stefan M, Itzel Timo, Rubner Christoph, Kesselring Rebecca, Griesshammer Eva, Evert Matthias, Teufel Andreas, Schlitt Hans J, Fichtner-Feigl Stefan

机构信息

Department of Surgery, University Medical Center Regensburg, Regensburg, Germany.

Institute of Pathology, University Medical Center Regensburg, Regensburg, Germany.

出版信息

Oncotarget. 2017 Aug 9;8(41):71002-71011. doi: 10.18632/oncotarget.20238. eCollection 2017 Sep 19.

DOI:10.18632/oncotarget.20238
PMID:29050338
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5642613/
Abstract

BACKGROUND & AIMS: The immunological microenvironment of HCC influences patient outcome, however, the role of B cells remains unclear. This study investigated effects of local B-cell infiltration in HCC cohorts on patient survival and immunological and molecular tumor microenvironment.

RESULTS

Unsupervised gene expression analysis of full cancer transcriptomes (N=2158) revealed a highly co-regulated immunological cluster in HCC that mainly contained immunoglobulin fragments. More specifically, in an independent patient cohort (N=242) that compares HCC with non tumorous liver tissue high expression of these B-cell associated genes was associated with better patient outcome (P=0.0149). Conclusively, the immunohistochemical analysis of another independent cohort of resected HCCs (N=119) demonstrated that infiltration of HCCs by CD20 cells (P=0.004) and CD79a cells (P=0.038) at the infiltrative margin were associated with prolonged patient survival. Further, the immunoglobulin fragments that were identified in the gene expression analysis were detected at high levels in patients with dense B-cell infiltration.

METHODS

Gene expression of 2 independent HCC tissue databases was compared using microarrays. Additionally, tissue of resected HCCs was stained for CD20, CD79a and immunoglobulins and analysed for the respective cell numbers separately for tumor, infiltrative margin and distant liver stroma. These findings were correlated with clinical data and patient outcome.

CONCLUSIONS

Infiltration of HCCs by B cells is associated with prolonged patient survival. Further, a distinct B-cell like immunoglobulin profile of HCCs was identified that goes along with better patient outcome. We suggest that B cells contribute to local tumor control by secreting increased levels of immunoglobulins with antitumor activity.

摘要

背景与目的

肝癌的免疫微环境影响患者预后,然而,B细胞的作用仍不明确。本研究调查了肝癌队列中局部B细胞浸润对患者生存以及免疫和分子肿瘤微环境的影响。

结果

对完整癌症转录组(N = 2158)进行无监督基因表达分析,发现肝癌中存在一个高度共调控的免疫簇,主要包含免疫球蛋白片段。更具体地说,在一个将肝癌与非肿瘤肝组织进行比较的独立患者队列(N = 242)中,这些B细胞相关基因的高表达与更好的患者预后相关(P = 0.0149)。最后,对另一组独立的切除肝癌样本(N = 119)进行免疫组织化学分析表明,浸润边缘的CD20细胞(P = 0.004)和CD79a细胞(P = 0.038)浸润与患者生存期延长相关。此外,在基因表达分析中鉴定出的免疫球蛋白片段在B细胞密集浸润的患者中高水平存在。

方法

使用微阵列比较2个独立肝癌组织数据库的基因表达。此外,对切除的肝癌组织进行CD20、CD79a和免疫球蛋白染色,并分别分析肿瘤、浸润边缘和远处肝基质中各自的细胞数量。将这些发现与临床数据和患者预后相关联。

结论

B细胞浸润肝癌与患者生存期延长相关。此外,还鉴定出一种与更好患者预后相关的独特的类似B细胞的免疫球蛋白谱。我们认为B细胞通过分泌增加水平的具有抗肿瘤活性的免疫球蛋白来促进局部肿瘤控制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b947/5642613/dda84d0ff181/oncotarget-08-71002-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b947/5642613/2b4bc22f1bc9/oncotarget-08-71002-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b947/5642613/7d6809c2ac78/oncotarget-08-71002-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b947/5642613/15cb2f5fee0b/oncotarget-08-71002-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b947/5642613/c8b8bd48fd3a/oncotarget-08-71002-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b947/5642613/2b16654114f4/oncotarget-08-71002-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b947/5642613/dda84d0ff181/oncotarget-08-71002-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b947/5642613/2b4bc22f1bc9/oncotarget-08-71002-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b947/5642613/7d6809c2ac78/oncotarget-08-71002-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b947/5642613/15cb2f5fee0b/oncotarget-08-71002-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b947/5642613/c8b8bd48fd3a/oncotarget-08-71002-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b947/5642613/2b16654114f4/oncotarget-08-71002-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b947/5642613/dda84d0ff181/oncotarget-08-71002-g006.jpg

相似文献

1
Tumor-infiltrating B cells producing antitumor active immunoglobulins in resected HCC prolong patient survival.在切除的肝癌中产生抗肿瘤活性免疫球蛋白的肿瘤浸润性B细胞可延长患者生存期。
Oncotarget. 2017 Aug 9;8(41):71002-71011. doi: 10.18632/oncotarget.20238. eCollection 2017 Sep 19.
2
Tumor-infiltrating, interleukin-33-producing effector-memory CD8(+) T cells in resected hepatocellular carcinoma prolong patient survival.切除的肝癌组织中浸润的、产生白细胞介素-33 的效应记忆性 CD8(+) T 细胞可延长患者生存期。
Hepatology. 2015 Jun;61(6):1957-67. doi: 10.1002/hep.27728. Epub 2015 Mar 18.
3
Immune Architecture of Colorectal Lung Metastases and Implications for Patient Survival.结直肠癌肺转移灶的免疫结构及其对患者生存的影响
Eur Surg Res. 2016;57(3-4):186-196. doi: 10.1159/000447555. Epub 2016 Jul 22.
4
Landscape of infiltrating B cells and their clinical significance in human hepatocellular carcinoma.人肝细胞癌中浸润性B细胞的图谱及其临床意义
Oncoimmunology. 2019 Feb 7;8(4):e1571388. doi: 10.1080/2162402X.2019.1571388. eCollection 2019.
5
Immunovascular microenvironment in relation to prognostic heterogeneity of WNT/β-catenin-activated hepatocellular carcinoma.与WNT/β-连环蛋白激活的肝细胞癌预后异质性相关的免疫血管微环境
Hepatol Res. 2023 Apr;53(4):344-356. doi: 10.1111/hepr.13869. Epub 2023 Jan 11.
6
Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.具有“干性”相关标志物表达的人肝细胞癌:角蛋白 19 的表达与预后不良相关。
Hepatology. 2011 Nov;54(5):1707-17. doi: 10.1002/hep.24559.
7
Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma.环氧化酶-2表达与人原发性肝细胞癌中CD4+浸润性T淋巴细胞存在之间的相关性。
Hepatogastroenterology. 2008 Mar-Apr;55(82-83):345-50.
8
Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.肝脏浸润性CD8(+)淋巴细胞作为丙型肝炎病毒相关肝细胞癌肿瘤复发的预后因素
Liver Int. 2016 Mar;36(3):434-44. doi: 10.1111/liv.12927. Epub 2015 Sep 29.
9
A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.一种肝细胞癌特异性腺病毒变体CV890,与阿霉素联合使用可消除远处的人类肝脏肿瘤。
Cancer Res. 2001 Sep 1;61(17):6428-36.
10
Prognosis according to histochemical analysis of liver metastases removed at liver resection.根据肝切除时肝转移灶的组织化学分析的预后。
Br J Surg. 2014 Dec;101(13):1681-91. doi: 10.1002/bjs.9627. Epub 2014 Oct 21.

引用本文的文献

1
ACLY inhibition promotes tumour immunity and suppresses liver cancer.ACLY抑制可促进肿瘤免疫并抑制肝癌。
Nature. 2025 Jul 30. doi: 10.1038/s41586-025-09297-0.
2
Multifaceted function of B cells in tumorigenesis.B细胞在肿瘤发生中的多方面功能。
Front Med. 2025 Apr;19(2):297-317. doi: 10.1007/s11684-025-1127-5. Epub 2025 Mar 22.
3
Landscape of B lymphocytes and plasma cells in digestive tract carcinomas.消化道癌中B淋巴细胞和浆细胞的情况

本文引用的文献

1
IL-17A promotes migration and tumor killing capability of B cells in esophageal squamous cell carcinoma.白细胞介素-17A促进食管鳞状细胞癌中B细胞的迁移和肿瘤杀伤能力。
Oncotarget. 2016 Apr 19;7(16):21853-64. doi: 10.18632/oncotarget.7869.
2
Mucin 1-specific B cell immune responses and their impact on overall survival in breast cancer patients.黏蛋白1特异性B细胞免疫反应及其对乳腺癌患者总生存期的影响。
Oncoimmunology. 2015 Jun 5;5(1):e1057387. doi: 10.1080/2162402X.2015.1057387. eCollection 2016.
3
Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma.
Ann Gastroenterol. 2025 Jan-Feb;38(1):1-11. doi: 10.20524/aog.2024.0936. Epub 2024 Dec 12.
4
Beyond Cancer Cells: How the Tumor Microenvironment Drives Cancer Progression.超越癌细胞:肿瘤微环境如何推动癌症进展。
Cells. 2024 Oct 9;13(19):1666. doi: 10.3390/cells13191666.
5
Immune characteristics of dedifferentiated retroperitoneal liposarcomas and the reliability of regional samples in evaluating their tumor immune microenvironments.去分化型腹膜后脂肪肉瘤的免疫特征及区域样本评估其肿瘤免疫微环境的可靠性。
World J Surg Oncol. 2024 Jan 23;22(1):25. doi: 10.1186/s12957-023-03295-0.
6
Elevated NDC1 expression predicts poor prognosis and correlates with immunity in hepatocellular carcinoma.NDC1表达升高预示肝细胞癌预后不良并与免疫相关。
J Gastrointest Oncol. 2023 Feb 28;14(1):245-264. doi: 10.21037/jgo-22-1166.
7
M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular carcinoma.构建新型预后标志物,揭示免疫景观,筛选肝癌中 M2 样肿瘤相关巨噬细胞相关生物标志物。
Front Immunol. 2022 Sep 13;13:994019. doi: 10.3389/fimmu.2022.994019. eCollection 2022.
8
Preoperative Prognostic Nutritional Index May Be a Strong Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation.术前预后营养指数可能是肝移植后肝细胞癌复发的有力预测指标。
J Hepatocell Carcinoma. 2022 Jul 27;9:649-660. doi: 10.2147/JHC.S366107. eCollection 2022.
9
Approaches to spatially resolving the tumour immune microenvironment of hepatocellular carcinoma.解析肝细胞癌肿瘤免疫微环境空间特征的方法
Ther Adv Med Oncol. 2022 Jul 22;14:17588359221113270. doi: 10.1177/17588359221113270. eCollection 2022.
10
The Functional Roles of Immune Cells in Primary Liver Cancer.免疫细胞在原发性肝癌中的功能作用
Am J Pathol. 2022 Jun;192(6):826-836. doi: 10.1016/j.ajpath.2022.02.004. Epub 2022 Mar 23.
肿瘤浸润性B细胞与T细胞之间的相互作用控制着肝细胞癌的进展。
Gut. 2017 Feb;66(2):342-351. doi: 10.1136/gutjnl-2015-310814. Epub 2015 Dec 15.
4
Chemokine (C-X-C motif) receptor 3-positive B cells link interleukin-17 inflammation to protumorigenic macrophage polarization in human hepatocellular carcinoma.趋化因子(C-X-C 基序)受体 3 阳性 B 细胞将白细胞介素-17 炎症与人类肝细胞癌中促肿瘤发生的巨噬细胞极化联系起来。
Hepatology. 2015 Dec;62(6):1779-90. doi: 10.1002/hep.28020. Epub 2015 Aug 29.
5
Tumor-infiltrating, interleukin-33-producing effector-memory CD8(+) T cells in resected hepatocellular carcinoma prolong patient survival.切除的肝癌组织中浸润的、产生白细胞介素-33 的效应记忆性 CD8(+) T 细胞可延长患者生存期。
Hepatology. 2015 Jun;61(6):1957-67. doi: 10.1002/hep.27728. Epub 2015 Mar 18.
6
Quantitative analysis of immunoglobulin subclasses and subclass specific glycosylation by LC-MS-MRM in liver disease.液相色谱-质谱-多反应监测法对肝病中免疫球蛋白亚类及亚类特异性糖基化的定量分析
J Proteomics. 2015 Feb 26;116:24-33. doi: 10.1016/j.jprot.2014.12.020. Epub 2015 Jan 9.
7
Correlation analysis of peripheral blood T cell subgroups, immunoglobulin and prognosis of early hepatocellular carcinoma after hepatectomy.肝切除术后早期肝细胞癌外周血T细胞亚群、免疫球蛋白与预后的相关性分析
Int J Clin Exp Med. 2014 Nov 15;7(11):4282-90. eCollection 2014.
8
Antitumor effector B cells directly kill tumor cells via the Fas/FasL pathway and are regulated by IL-10.抗肿瘤效应B细胞通过Fas/FasL途径直接杀伤肿瘤细胞,并受白细胞介素-10调控。
Eur J Immunol. 2015 Apr;45(4):999-1009. doi: 10.1002/eji.201444625. Epub 2015 Jan 21.
9
CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma.CXCL17表达预示肝细胞癌预后不良,并与不良免疫浸润相关。
PLoS One. 2014 Oct 10;9(10):e110064. doi: 10.1371/journal.pone.0110064. eCollection 2014.
10
Regulatory B cells accelerate hepatocellular carcinoma progression via CD40/CD154 signaling pathway.调节性 B 细胞通过 CD40/CD154 信号通路加速肝细胞癌进展。
Cancer Lett. 2014 Dec 28;355(2):264-72. doi: 10.1016/j.canlet.2014.09.026. Epub 2014 Oct 6.